Literature DB >> 18988735

New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals.

Luigi Zecca1, Chiara Bellei, Patrizia Costi, Alberto Albertini, Enrico Monzani, Luigi Casella, Mario Gallorini, Luigi Bergamaschi, Alberto Moscatelli, Nicholas J Turro, Melvin Eisner, Pier Raimondo Crippa, Shosuke Ito, Kazumasa Wakamatsu, William D Bush, Weslyn C Ward, John D Simon, Fabio A Zucca.   

Abstract

Neuronal pigments of melanic type were identified in the putamen, cortex, cerebellum, and other major regions of human brain. These pigments consist of granules 30 nm in size, contained in organelles together with lipid droplets, and they accumulate in aging, reaching concentrations as high as 1.5-2.6 microg/mg tissue in major brain regions. These pigments, which we term neuromelanins, contain melanic, lipid, and peptide components. The melanic component is aromatic in structure, contains a stable free radical, and is synthesized from the precursor molecule cysteinyl-3,4-dihydroxyphenylalanine. This contrasts with neuromelanin of the substantia nigra, where the melanic precursor is cysteinyl-dopamine. These neuronal pigments have some structural similarities to the melanin found in skin. The precursors of lipid components of the neuromelanins are the polyunsaturated lipids present in the surrounding organelles. The synthesis of neuromelanins in the various regions of the human brain is an important protective process because the melanic component is generated through the removal of reactive/toxic quinones that would otherwise cause neurotoxicity. Furthermore, the resulting melanic component serves an additional protective role through its ability to chelate and accumulate metals, including environmentally toxic metals such as mercury and lead.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18988735      PMCID: PMC2582310          DOI: 10.1073/pnas.0808768105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Tyrosinase: a developmentally specific major determinant of peripheral dopamine.

Authors:  Graeme Eisenhofer; Hua Tian; Courtney Holmes; Jun Matsunaga; Suzanne Roffler-Tarlov; Vincent J Hearing
Journal:  FASEB J       Date:  2003-07       Impact factor: 5.191

Review 2.  Neurotoxicity of organomercurial compounds.

Authors:  Coral Sanfeliu; Jordi Sebastià; Rosa Cristòfol; Eduard Rodríguez-Farré
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

3.  The structure of neuromelanin as studied by chemical degradative methods.

Authors:  Kazumasa Wakamatsu; Kenichi Fujikawa; Fabio A Zucca; Luigi Zecca; Shosuke Ito
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

Review 4.  Rett Syndrome -- an update.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2003-06       Impact factor: 3.575

5.  Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.

Authors:  Chang-Lin Liang; Omar Nelson; Umar Yazdani; Parichehr Pasbakhsh; Dwight C German
Journal:  J Comp Neurol       Date:  2004-05-17       Impact factor: 3.215

6.  Identification and quantification of dolichol and dolichoic acid in neuromelanin from substantia nigra of the human brain.

Authors:  Weslyn C Ward; Ziqiang Guan; Fabio A Zucca; Ruggero G Fariello; Reza Kordestani; Luigi Zecca; Christian R H Raetz; John D Simon
Journal:  J Lipid Res       Date:  2007-04-19       Impact factor: 5.922

7.  Decreased nigral neuromelanin in Alzheimer's disease.

Authors:  Marc G Reyes; Francesco Faraldi; Robert Rydman; Charles Ce Wang
Journal:  Neurol Res       Date:  2003-03       Impact factor: 2.448

8.  The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease.

Authors:  Luigi Zecca; Ruggero Fariello; Peter Riederer; David Sulzer; Alberto Gatti; Davide Tampellini
Journal:  FEBS Lett       Date:  2002-01-16       Impact factor: 4.124

9.  Interaction of human substantia nigra neuromelanin with lipids and peptides.

Authors:  L Zecca; P Costi; C Mecacci; S Ito; M Terreni; S Sonnino
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

10.  Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles.

Authors:  D Sulzer; J Bogulavsky; K E Larsen; G Behr; E Karatekin; M H Kleinman; N Turro; D Krantz; R H Edwards; L A Greene; L Zecca
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

View more
  68 in total

Review 1.  γ-Glutamylamines and neurodegenerative diseases.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Amino Acids       Date:  2012-03-10       Impact factor: 3.520

Review 2.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

3.  Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line.

Authors:  Irmgard Paris; Carolina Perez-Pastene; Sergio Cardenas; Patricio Iturriaga-Vasquez; Patricio Iturra; Patricia Muñoz; Eduardo Couve; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2010-01-20       Impact factor: 3.911

4.  A reappraisal of Fe(III) adsorption by melanin.

Authors:  Rhiannon Lee Schroeder; Jacobus Petrus Gerber
Journal:  J Neural Transm (Vienna)       Date:  2014-05-21       Impact factor: 3.575

5.  Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats.

Authors:  Fang Du; Zhong-Ming Qian; Qianqian Luo; Wing-Ho Yung; Ya Ke
Journal:  Mol Neurobiol       Date:  2014-08-13       Impact factor: 5.590

Review 6.  The role of iron in brain ageing and neurodegenerative disorders.

Authors:  Roberta J Ward; Fabio A Zucca; Jeff H Duyn; Robert R Crichton; Luigi Zecca
Journal:  Lancet Neurol       Date:  2014-10       Impact factor: 44.182

Review 7.  Chemiexcitation and Its Implications for Disease.

Authors:  Douglas E Brash; Leticia C P Goncalves; Etelvino J H Bechara
Journal:  Trends Mol Med       Date:  2018-05-08       Impact factor: 11.951

8.  The expanding role and presence of neuromelanins in the human brain - why gray matter is gray.

Authors:  Vincent J Hearing
Journal:  Pigment Cell Melanoma Res       Date:  2008-12-19       Impact factor: 4.693

9.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05

10.  Neuromelanin Modulates Heterocyclic Aromatic Amine-Induced Dopaminergic Neurotoxicity.

Authors:  Vivek Lawana; Se Young Um; Jean-Christophe Rochet; Robert J Turesky; Jonathan H Shannahan; Jason R Cannon
Journal:  Toxicol Sci       Date:  2020-01-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.